Mon Jan 05 08:15:44 UTC 2026: Okay, here’s a news article summarizing the text you provided:

AIIMS Delhi Doctor Slams Zomato CEO’s “Temple” Device as a “Fancy Toy” with No Scientific Merit

New Delhi, India – A prominent AI researcher and radiologist at AIIMS Delhi, Dr. Suvrankar Datta, has publicly criticized Zomato CEO Deepinder Goyal’s “Temple” device, dismissing it as a frivolous expense for the wealthy with no proven medical value.

The “Temple” device, developed by Goyal’s venture, Continue Research, is an experimental wearable designed to measure cerebral blood flow in real-time. Goyal has theorized that it could shed light on the role of gravity in human aging. He has invested $25 million of his own money into this venture.

However, Dr. Datta, an expert in Arterial Stiffness and Pulse Wave Velocity, a predictor of cardiovascular mortality, took to X (formerly Twitter) to strongly advise the public against purchasing the device. “As a physician-scientist… I can assure you that this device currently has 0 scientific standing as a useful device,” he wrote. “Do not waste your hard-earned money to buy fancy toys billionaires can afford to waste money on.”

Dr. Datta emphasized that the device is still in an experimental phase and lacks clinical validation, urging consumers to be wary of investing their savings in unproven technologies.

Goyal showcased the Temple device in silver on Raj Shamani’s Figuring Out podcast on January 3rd, and spotted wearing a golden version of it near his right eye at a Children’s Day event in November. The device is not yet available for public sale.

This criticism raises questions about the scientific basis and potential benefits of the “Temple” device, as well as the ethical considerations surrounding the promotion of unproven medical technologies to the public.

Read More